Low-vs high-frequency repetitive transcranial magnetic stimulation as an add-on treatment for refractory depression

Frontiers in Psychiatry

Volumn 3, Issue MAR, 2012, Pages

  Eche, Julien ^a,b,c   Mondino, Marine ^a,b,c   Haesebaert, Frederic ^a,b,c   Saoud, Mohamed ^a,b,c   Poulet, Emmanuel ^a,b,c   Brunelin, Jerome ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c EA461S   (France)

Author keywords

Depression; Dorsolateral prefrontal cortex; rTMS; Transcranial magnetic stimulation; Venlafaxine

Indexed keywords

PLACEBO; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; FREQUENCY MODULATION; HIGH FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; HUMAN; LOW FREQUENCY REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; MAJOR DEPRESSION; MALE; MONOTHERAPY; MORNING DOSAGE; NERVE STIMULATION; PATIENT ASSESSMENT; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION;

EID: 84866863509     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00013     Document Type: Article

References (17)

1. Baldomero, E. B., Ubago, J. G., Cer-cos, C. L., Ruiloba, J. V., Calvo, C. G., and Lopez, R. P. (2005). Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. Depress. Anxiety 22, 68-76.
2. Bares, M., Kopecek, M., Novak, T., Stopkova, P., Sos, P., Kozeny, J., Brunovsky, M., and Hoschl, C. (2009). Lowfrequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. J. Affect. Disord. 118, 94-100.
3. Brunelin, J., Poulet, E., Boeuve, C, Zeroug-Vial, H., D'Amato, T., and Saoud, M. (2007). Efficacy of repetitive transcranial magnetic stimulation (rTMS) in major depression. Encephale 33, 126-134.
4. Fava, M. (2003). Diagnosis and definition of treatment-resistant depression. Biol. Psychiatry 53, 649-659.
5. Fitzgerald, P. B., Hoy, K., Daskalakis, Z. J., and Kulkarni, J. (2009). A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress. Anxiety 26, 229-234.
6. George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., Holtzheimer, P. E. Ill, Schwartz, T., and Sackeim, H. A. (2010). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch. Gen. Psychiatry 67, 507-516.
7. Hoppner, J., Schulz, M., Irmisch, G., Mau, R., Schlafke, D., and Richter, J. (2003). Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur. Arch. Psychiatry Clin. Neurosci. 253, 103-109.
8. Isenberg, K., Downs, D., Pierce, K., Svarakic, D., Garcia, K., Jarvis, M., North, C, and Kormos, T. C. (2005). Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. Ann. Clin. Psychiatry 17, 153-159.
9. Montgomery, S. A., and Asberg, M. (1979). A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 383-389.
10. Pallanti, S., Bernardi, S., Di Rollo, A., Antonini, S., and Quercioli, L. (2010). Unilateral lowfrequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience 167, 323-328.
11. Poulet, E., Brunelin, J., Boeuve, C., Lerond, J., D'Amato, T., Dalery, J., and Saoud, M. (2004). Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment. Eur. Psychiatry 19, 382-383.
12. Rossini, D., Lucca, A., Magri, L., Malaguti, A., Smeraldi, E., Colombo, C, and Zanardi, R. (2010). A symptom-specific analysis of the effect of high-frequency left or low-frequency right transcranial magnetic stimulation over the dorso-lateral prefrontal cortex in major depression. Neuropsychobiology 62, 91-97.
13. Rumi, D. O., Gattaz, W. E, Rigo-natti, S. P., Rosa, M. A., Fregni, E, Rosa, M. O., Mansur, C., Myczkowski, M. L., Moreno, R. A., and Marcolin, M. A. (2005). Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 57, 162-126.
14. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L, Biggs, M. M., Warden, D., Luther, J. E, Shores-Wilson, K., Niederehe, G., and Fava M for the STAR*D Study Team. (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl J. Med. 354, 1231-1242.
15. Steffens, D. C, Krishnan, K. R., and Helms, M. J. (1997). Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress. Anxiety 6, 10-18.
16. Stern, W. M., Tormos, J. M., Press, D. Z., Pearlman, C, and Pascual-Leone, A. (2007). Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. J. Neu-ropsychiatry Clin. Neurosci. 19, 179-186.
17. Theodore, W H., Hunter, K., Chen, R., Vega-Bermudez, E, Boroojerdi, B., Reeves-Tyer, P., Werhahn, K., Kelley, K. R., and Cohen, L. (2002). Tran-scranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology 59, 560-562.